# US 8,278,313 B2 · Macrocyclic spiro pyrimidine derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,313 B2
- Document ID: US8278313B2
- Status: Granted
- Kind: B2
- Application number: 12/401,385
- Filed: 2009-03-10
- Published: 2009-09-17
- Granted: 2012-10-02
- Earliest claimed: 2008-03-11
- Assignees: Abbott Laboratories
- Inventors: Huaqing Liu; John R. Koenig; Marlon D. Cowart; Lawrence A. Black
- Web page: https://patentgrep.com/patent/US8278313B2

## CPC

- C07D 239/95: with hetero atoms directly attached in positions 2 and 4
- A61P 11/06: Antiasthmatics
- A61P 25/00: Drugs for disorders of the nervous system
- C07D 471/10: Spiro-condensed systems
- C07D 487/10: Spiro-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Macrocyclic Spiro pyrimidine compounds of formula (I): compositions comprising such compounds, methods for making the compounds, and methods of treating and preventing the progression of diseases, conditions, and disorders using such compounds and compositions are described herein.

## Claims

### Claim 1

A compound of formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
G1 is CH2CH2;
G2 is CH2;
wherein each carbon of G1 and G2 may be optionally substituted with one or more groups selected from acyl, acyloxy, alkenyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, alkoxycarbonyl, alkyl, alkylcarbonyl, alkylcycloalkyl, alkylsulfonyl, alkylthio, alkynyl, amido, carboxy, cyano, cyanoalkyl, cycloalkoxyalkyl, cycloalkyl, fluoroalkoxy, fluoroalkyl, fluorocycloalkyl, fluorocycloalkylalkyl, formyl, haloalkoxy, haloalkyl, halogen, hydroxy, hydroxyalkyl, mercapto, nitro, and oxo;
G4 is a bond;
R1 is selected from hydrogen, NH2, —NH(acyl), —NH(alkyl), —N(alkyl)2, —NH(C═O)aryl, —NH-alkylene(NR8R9), —NH(C═O)-alkylene(NR8R9), —NR8(C═O)NR8R9, —NH-alkylene-heteroaryl, —NHOH, —NHOCH3, —O-alkylene(NR8R9), alkoxy, alkoxycarbonyl, alkyl, carboxy, —(C═O)—(NR8R9), —(C═O)—NH-alkylene(NR8R9), cyano, cyanoalkyl, cycloalkyl, fluoroalkyl, fluorocycloalkyl, hydroxyalkyl, and piperazinyl;
R8 and R9 each are each independently selected from acyl, alkoxyalkyl, alkoxycarbonyl, alkyl, alkylcarbonyl, alkylcycloalkyl, alkylsulfonyl, amido, aryl, cyanoalkyl, cycloalkoxyalkyl, cycloalkyl, fluorocycloalkyl, fluorocycloalkylalkyl, heteroaryl, heterocyclyl, hydrogen, formyl, hydroxy, and hydroxyalkyl;
R10 and R11 taken together are alkylene, —OCH2CH2O—, —OCH2CH2CH2O—, or —CH2CH2OCH2CH2—,
A1is
and
wherein each carbon atom of groups A1may be optionally substituted with one or more groups selected from acyl, acyloxy, alkenyl, alkoxy, alkoxyalkoxy, alkoxyalkyl, alkoxycarbonyl, alkyl, alkylcarbonyl, alkylcycloalkyl, alkylsulfonyl, alkylthio, alkynyl, amido, carboxy, cyano, cyanoalkyl, cycloalkoxyalkyl, cycloalkyl, fluoroalkoxy, fluoroalkyl, fluorocycloalkyl, fluorocycloalkylalkyl, formyl, haloalkoxy, haloalkyl, halogen, hydroxy, hydroxyalkyl, mercapto, and nitro.

### Claim 2 (depends on 1)

The compound of claim 1, wherein R1is selected from hydrogen, NHOH, —NHOCH3, alkoxy, cyano, cyanoalkyl, cycloalkyl, fluoroalkyl, fluorocycloalkyl, and hydroxyalkyl.

### Claim 3 (depends on 1)

The compound of claim 1, wherein R1is hydrogen, NH2, —NHCH3, —NH(C═O)CH3, —NH(C═O)phenyl, —NH(C═O)NHCH3, —NH(C═O)CH2NH2, —NH(C═O)CH2NHCH3, —NH(C═O)CH2N(CH3)2, —NH(C═O)CH2CH2CH2NH2, —NHCH2(pyridin-3-yl), —NHCH2(imidazol-4-yl), —NHCH2CH2N(CH3)2, piperazin-1-yl, —(C═O)OCH3, or —(C═O)OH.

### Claim 4 (depends on 1)

The compound of claim 1, wherein R10and R11 taken together are —CH2CH2—, —CH2CH2CH2—, —CH2CH2CH2CH2—, —CH2CH2CH2CH2CH2—, —CH2CH2CH2CH2CH2CH2—, —OCH2CH2O—, —OCH2CH2CH2O—, or —CH2CH2OCH2CH2.

### Claim 5 (depends on 1)

The compound of claim 1, wherein the compound is selected form the group consisting of:
4′-(3-(methylamino)azetidin-1-yl)-6′,7′-dihydro-5′H-spiro[cyclopentane-1,8′-quinazolin ]-2′-amine; and
4′-(3-aminoazetidin-1-yl)-6′,7′-dihydro-5′H-spiro[cyclopentane-1,8′-quinazolin]-2′-amine.

### Claim 6 (depends on 1)

A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.
